[Ip-health] Statement-Modi visit: a matter of life and death

Peter Maybarduk pmaybarduk at citizen.org
Mon Jun 26 12:52:35 PDT 2017




Trump and Modi Discussions: A Matter of Life and Death

Statement of Peter Maybarduk, Director, Public Citizen’s Access to Medicines Program

June 26, 2017

Contact: Peter Maybarduk, pmaybarduk at citizen.org<mailto:pmaybarduk at citizen.org>, (202) 588-7755
Don Owens, dowens at citizen.org<mailto:dowens at citizen.org>, (202) 588-7767

Note: President Donald Trump meets with Indian Prime Minister Narendra Modi at the White House today. Politico quoted a senior White House official Friday saying, “The U.S. is looking for things like stronger intellectual property protections …[.]”  On Friday, a draft executive order<http://qz.salsalabs.com/dia/track.jsp?key=-1&url_num=1&url=https%3A%2F%2Fwww.citizen.org%2Fmedia%2Fpress-releases%2Fdraft-trump-executive-order-abandons-promises-challenge-big-pharma-and-make> on pharmaceutical pricing leaked, including a provision that would order U.S. agency heads to review foreign countries’ pharmaceutical pricing and intellectual property rules.

Blasé Washington-speak about intellectual property masks the life-and-death nature of what Trump and Modi are discussing today. On access to medicines alone, these leaders hold millions of lives in their hands. As the draft executive order <http://qz.salsalabs.com/dia/track.jsp?key=-1&url_num=2&url=https%3A%2F%2Fwww.citizen.org%2Fmedia%2Fpress-releases%2Fdraft-trump-executive-order-abandons-promises-challenge-big-pharma-and-make> shows, President Trump wants to make foreign countries pay more for medicine, even though that will do nothing to make medicines more accessible in the United States, and exorbitant prices already cost lives around the world.

India is the world’s leading supplier of affordable generic medicines. Millions of people in developing countries depend on this supply. The Trump administration proposal to clamp down on these lifesaving medicines serves Big Pharma’s corporate interests.

###

View this statement on our press page.<http://qz.salsalabs.com/dia/track.jsp?key=-1&url_num=3&url=https%3A%2F%2Fwww.citizen.org%2Fmedia%2Fpress-releases>




More information about the Ip-health mailing list